---
category: news
title: "Poolbeg Pharma AI model of respiratory syncytial virus starts analysis"
excerpt: "Poolbeg Pharma PLC on Monday said its build and optimisation of an artificial intelligence model of respiratory syncytial virus data is complete. RSV is an infectious virus that affects around 50 million people per year,"
publishedDateTime: 2022-06-27T09:47:00Z
originalUrl: "https://www.lse.co.uk/news/poolbeg-pharma-ai-model-of-respiratory-syncytial-virus-starts-analysis-1anogmeonegv03i.html"
webUrl: "https://www.lse.co.uk/news/poolbeg-pharma-ai-model-of-respiratory-syncytial-virus-starts-analysis-1anogmeonegv03i.html"
type: article
quality: 37
heat: -1
published: false

provider:
  name: London South East
  domain: lse.co.uk

topics:
  - AI

images:
  - url: "https://static.lse.co.uk/images/logo-og.jpg"
    width: 600
    height: 346
    isCached: true

related:
  - title: "Poolbeg Pharma Partner Completes AI Model for RSV Drug Identification"
    excerpt: "Poolbeg Pharma PLC said Monday that partner OneThree Biotech has completed its artificial intelligence model optimization to identify treatments for respiratory syncytial virus, with results expected in the fourth quarter. The pharmaceutical company said ..."
    publishedDateTime: 2022-06-27T09:27:00Z
    webUrl: "https://www.marketwatch.com/story/poolbeg-pharma-partner-completes-ai-model-for-rsv-drug-identification-271656321540"
    ampWebUrl: "https://www.marketwatch.com/amp/story/poolbeg-pharma-partner-completes-ai-model-for-rsv-drug-identification-271656321540"
    cdnAmpWebUrl: "https://www-marketwatch-com.cdn.ampproject.org/c/s/www.marketwatch.com/amp/story/poolbeg-pharma-partner-completes-ai-model-for-rsv-drug-identification-271656321540"
    type: article
    provider:
      name: MarketWatch
      domain: marketwatch.com
    quality: 87
    images:
      - url: "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png"
        width: 1200
        height: 630
        isCached: true
  - title: "Poolbeg Pharma is advancing an AI venture to help combat RSV"
    excerpt: "CEO Jeremy Skillington joined Proactive talk about the company's artificial intelligence venture which is being used to model respiratory syncytial virus (RSV). It comes as its partner OneThree Biotech completed a tailored AI model using Poolbeg’s data gathered through a human challenge study into RSV."
    publishedDateTime: 2022-06-27T09:13:00Z
    webUrl: "https://www.proactiveinvestors.com/companies/news/985891/poolbeg-pharma-is-advancing-an-ai-venture-to-help-combat-rsv-985891.html"
    ampWebUrl: "https://www.proactiveinvestors.com/companies/amp/news/985891"
    cdnAmpWebUrl: "https://www-proactiveinvestors-com.cdn.ampproject.org/c/s/www.proactiveinvestors.com/companies/amp/news/985891"
    type: article
    provider:
      name: Proactiveinvestors
      domain: proactiveinvestors.com
    quality: 37

secured: "pF/Znw/IZUDa9u3fcMu0ZTL9GVWx5tTb6pb1hAU3U9gdWbf17mkPcgdFtXVZbvQ+nqTL+ba96m+1cn6WVg1vsQhAANMN+s/17dujCfMhftfqRwBB3PJv3RByP9WfNObiYpZQgoe1wSGbjilLPIZ6HALyar2Hc7TsQvTPzujwX+3jPvQ3kVqCT92qil9+tH8x/iDDXh88o7DyehUanWM2i8ckw5FTbD9FemF9wZbVYo/XKlWdql6EZlFxo3SmFYYNkY7zH+v+T23O0EKVIahEHjZFglUQz/80yt1xdue1rzD3gxG4m37qocQb1cfaT1bAmoe1GR/nsP3tZ6aQ6vEJakygOiT0A6pLdSgv1FWQNvI=;nf74BoMqSJgYnzzesTUvZw=="
---

